-
Syntrix Publication in Bioorganic & Medicinal Chemistry Letters
-Congratulations to Syntrix scientists on their latest publication, which appeared in the journal Bioorganic & Medicinal Chemistry Letters. Abstract: Blockade of undesired neutrophil migration to sites of inflammation remains an area of substantial pharmaceutical interest….
2 -
Syntrix Wins U.S. Patent 9,000,142: Photocleavable Sense-Antisense Complex
-Congratulations to Syntrix scientists on their latest issued patent at the United States Patent and Trademark Office. Inventor: Zebala; John…
-
Syntrix Wins U.S. Patent 8,993,541: Aminopyrimidine Carboxamides as CXCR2 Modulators
-Congratulations to Syntrix scientists on their latest issued patent at the United States Patent and Trademark Office. Inventors: Maeda, Dean…
-
Syntrix wins U.S. patent 8,981,106: Pyrimidinecarboxamides as CXCR2 modulators
-Congratulations to Syntrix scientists on their latest issued patent at the United States Patent and Trademark Office. Inventors: Maeda, Dean…
-
Syntrix wins U.S. patent 8,969,365: Thiopyrimidinecarboxamides as CXCR1/2 modulators
-Congratulations to Syntrix scientists on their latest issued patent at the United States Patent and Trademark Office. Inventors: Maeda, Dean…
-
Syntrix publication in Journal of Medicinal Chemistry
-Congratulations to Syntrix scientists on their latest publication, which appeared in the ACS Journal of Medicinal Chemistry. Abstract: The G…
-
Syntrix wins U.S. patent 8,779,149: Aminopyridine and aminopyrimidine carboxamides as CXCR2 modulators
-Congratulations to Syntrix scientists on their latest issued patent at the United States Patent and Trademark Office. Inventors: Maeda, Dean…
-
Syntrix featured in the NIH Innovation Zone at 2014 Bio International Convention in San Diego, CA
-Syntrix was selected by the NIH to host a kiosk in the Innovation Zone, an area dedicated to showcasing Small…
News
Syntrix Pharmaceuticals > News